FORMES DE SELS DE MEGLUMINE DE L'ACIDE 2-((1R,4R)-4-(4-(5-(BENZOXAZOL-2-YLAMINO)PYRIDIN-2-YL)PHENYL)CYCLOHEXYL) ACETIQUE ET LEUR UTILISATION COMME INHIBITEURS DE DGAT1
The present invention relates to novel crystalline forms of meglumine salts of 2-((1 R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl) phenyl)cyclohexyl)acetic acid :Formule(I) and their use in the treatment or prevention of a condition or a disorder associated with DGATl activity in animals, particularly humans.